(Q39744193)

14 September 2017

title

CIS is a potent checkpoint in NK cell-mediated tumor immunity (English)

1 reference

14 September 2017

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Eva M Putz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Eva M Putz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Christopher E Andoniou

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Phillip P. Sharp

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Nicholas P D Liau

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Christopher J. Burns

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Daniel H Gray

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Dana S Hutchinson

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Gabrielle Belz

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Andrew I Webb

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Alex N Bullock

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Jeffrey J Babon

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Nicholas D Huntington

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Mariapia A Degli-Esposti

14

Mariapia A Degli-Esposti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

21

Sebastian Carotta

1 reference

7 June 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

Tatiana B Kolesnik

2

Tatiana B Kolesnik

1 reference

7 June 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

Edmond M Linossi

19

Edmond M Linossi

1 reference

7 June 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

Giuseppe Infusini

17

Giuseppe Infusini

1 reference

7 June 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

Kimberley Stannard

8

Kimberley Stannard

1 reference

7 June 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

Cyril Seillet

23

Cyril Seillet

1 reference

7 June 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

author name string

Rebecca B Delconte

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Laura F Dagley

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Jai Rautela

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Wei Shi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Jian-Guo Zhang

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Charis Teh

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Matt Firth

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Takashi Ushiki

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Caroline E Sanvitale

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Warren S Alexander

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Shawn S Li

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Sandra E Nicholson

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

language of work or name

English

0 references

publication date

23 May 2016

1 reference

14 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

816-824

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27213690%20AND%20SRC:MED&resulttype=core&format=json

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

7 June 2020

cites work

1 reference

The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?

21 January 2018

1 reference

Acquired resistance to immunotherapy and future challenges

21 January 2018

1 reference

Targeting natural killer cells and natural killer T cells in cancer

21 January 2018

1 reference

Developmental pathways that generate natural-killer-cell diversity in mice and humans

21 January 2018

1 reference

The unconventional expression of IL-15 and its role in NK cell homeostasis

21 January 2018

1 reference

STAT5-mediated signals sustain a TCR-initiated gene expression program toward differentiation of CD8 T cell effectors

21 January 2018

1 reference

Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1.

21 January 2018

1 reference

Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells.

21 January 2018

1 reference

Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12

21 January 2018

1 reference

Twenty proteins containing a C-terminal SOCS box form five structural classes

21 January 2018

1 reference

Suppression of cytokine signaling: the SOCS perspective

21 January 2018

1 reference

The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation

21 January 2018

1 reference

The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop

21 January 2018

1 reference

SOCS3 binds specific receptor–JAK complexes to control cytokine signaling by direct kinase inhibition

21 January 2018

1 reference

CIS associates with the interleukin-2 receptor beta chain and inhibits interleukin-2-dependent signaling

21 January 2018

1 reference

The signaling suppressor CIS controls proallergic T cell development and allergic airway inflammation.

21 January 2018

1 reference

Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance

21 January 2018

1 reference

Functional Network Pipeline Reveals Genetic Determinants Associated with in Situ Lymphocyte Proliferation and Survival of Cancer Patients

21 January 2018

1 reference

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

21 January 2018

1 reference

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma

21 January 2018

1 reference

Anti-programmed cell death protein-1/ligand-1 therapy in different cancers

21 January 2018

1 reference

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

21 January 2018

1 reference

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

21 January 2018

1 reference

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

21 January 2018

1 reference

Clinical utility of natural killer cells in cancer therapy and transplantation

21 January 2018

1 reference

The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions

21 January 2018

1 reference

Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy

21 January 2018

1 reference

SOCS3 negatively regulates IL-6 signaling in vivo

21 January 2018

1 reference

SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine.

21 January 2018

1 reference

Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor

21 January 2018

1 reference

Selectively expanding subsets of T cells in mice by injection of interleukin-2/antibody complexes: implications for transplantation tolerance

21 January 2018

1 reference

Analysis of Suppressor of Cytokine Signalling (SOCS) gene expression by real-time quantitative PCR.

21 January 2018

1 reference

Suppressor of Cytokine Signaling (SOCS) 5 utilises distinct domains for regulation of JAK1 and interaction with the adaptor protein Shc-1.

21 January 2018

1 reference

Phenylaminopyrimidines as inhibitors of Janus kinases (JAKs).

21 January 2018

1 reference

Universal sample preparation method for proteome analysis

21 January 2018

1 reference

Andromeda: a peptide search engine integrated into the MaxQuant environment

21 January 2018

1 reference

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

21 January 2018

1 reference

Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ.

21 January 2018

1 reference

Accurate protein complex retrieval by affinity enrichment mass spectrometry (AE-MS) rather than affinity purification mass spectrometry (AP-MS).

21 January 2018

1 reference

Crystal structure of the SOCS2-elongin C-elongin B complex defines a prototypical SOCS box ubiquitin ligase

21 January 2018

1 reference

Using peptide array to identify binding motifs and interaction networks for modular domains

21 January 2018

1 reference

In vitro JAK kinase activity and inhibition assays

21 January 2018

1 reference

Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity

21 January 2018

1 reference

Natural killer cells are essential for the ability of BRAF inhibitors to control BRAFV600E-mutant metastatic melanoma

21 January 2018

1 reference

DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors

21 January 2018

1 reference

CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis

21 January 2018

1 reference

Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy

21 January 2018

1 reference

Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer

21 January 2018

1 reference

Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer

21 January 2018

1 reference

Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs

21 January 2018

1 reference

A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors

21 January 2018

1 reference

12 December 2020

CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation

1 reference

12 December 2020

Distinct regions of the granulocyte colony-stimulating factor receptor are required for tyrosine phosphorylation of the signaling molecules JAK2, Stat3, and p42, p44MAPK

1 reference

12 December 2020

Type I IFN contributes to NK cell homeostasis, activation, and antitumor function

1 reference

12 December 2020